Thoracic radiotherapy in limited-stage small cell lung cancer
10.3760/cma.j.issn.1673-422X.2010.04.019
- VernacularTitle:局限期小细胞肺癌的胸部放射治疗
- Author:
Liu LAN
- Publication Type:Journal Article
- Keywords:
Carcinoma,small cell lung;
Neoplasm staging;
Radiotherapy
- From:
Journal of International Oncology
2010;37(4):296-299
- CountryChina
- Language:Chinese
-
Abstract:
The effective therapy of limited stage-small cell lung cancer( LS-SCLC) is combined chemotherapy and thoracic radiotherapy(TRT). Early thoracic irradiation is better than later one. Start of any treatment and end of radiotherapy less than 30 days is associated with improved survival in LS-SCLC patients. Concurrent chemoradiotherapy results in longer survival time than sequential and alternating chemoradiotherapy. There are no clear answers on optimal irradiation dose. Hyperfractinated irradiation may have therapeutic benefit compared with conventional irradiation.
